GLP-1s like Ozempic are among the most important drug breakthroughs ever
Their far-reaching potential could transform how chronic diseases are managed
IN THE HISTORY of medicine, a few drugs tower above all others. Humira for rheumatoid arthritis; Prozac for depression; statins to prevent heart disease and strokes. All have helped patients far beyond doctors’ initial expectations and continue to benefit millions of people every day. A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists.
Already have an account?Log in
Continue reading with 20% off
Save on a full-access subscription to explore all our independent journalism
Get startedDiscover more
The rockets are nifty, but it is satellites that make SpaceX valuable
Elon Musk’s space venture may soon be more valuable than Tesla
Who will control the next Congress?
The new president is much less likely than usual to see allies take charge on Capitol Hill
Has the war in Gaza radicalised young Palestinians?
After Gaza, how will the Palestinians try to build their state?
A year on, Israeli society is divided about the lessons of October 7th
Hawks and doves, religious and secular, right and left—all the old cleavages are resurfacing
The bloodshed in the Middle East is fast expanding
Israel seems certain to retaliate to Iran’s missile attack
What Hamas misunderstood about the Middle East
A war meant to draw in the militant group’s allies has instead left them battered
